Accelerating Change on Medicine’s Final Frontier

05 Aug 2016 Accelerating Change on Medicine’s Final Frontier Jordan Amadio (MD/MBA 2010) launched the world’s first neuroscience-focused accelerator to help entrepreneurs fast-track new treatments and technologiesRe: Mike Kelly (MBA 1990); David Gellis (MBA 2010); Vinod Nambudiri (MBA 2010); Greg Stock (MBA 1987); Jim Shinn (MBA 1981) by Robert S. Benchley Topics: ShareBar Photography by Susan Young “If you’re a brain geek, this is the best time in history to be alive,” says Jordan Amadio (MD/MBA 2010), founder and managing partner of NeuroLaunch, the world’s first neuroscience startup accelerator. “We’re on the brink of a golden age in neuroscience,” he says. “Billions of dollars in research funding is pouring into the space. We have tools that are unprecedented in their power, their ease of use, their accessibility, and their cost. The number of neuroscience articles…


Link to Full Article: Accelerating Change on Medicine’s Final Frontier